Bio-Rad Reports Third-Quarter 2019 Financial Results

Go back to Bio-Rad Reports Third-Quarter 2019 Financial Results

Bio-Rad Labs (BIO) Posts Q3 Loss of $8.68/Sh

October 31, 2019 4:18 PM EDT

Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of ($8.68), which does not compare to the analyst estimate of $1.40. This loss was negatively impacted by a decline of $390.6 million in the market value of equity securities that we hold, primarily related to our investment in... More